title: An evidence-based view on hyperbilirubinaemia.
abstract: BACKGROUND
  We conducted a review of the evidence which contributes to the current care of jaundiced newborn infants.
  
  
  METHODS
  Literature was searched for reviews and randomized controlled trials (RCTs).
  
  
  RESULTS
  Six Cochrane reviews and eight other reviews and eighteen recent RCTs are discussed.
  
  
  CONCLUSIONS
  Many children still suffer life-long consequences of severe hyperbilirubinaemia, which could almost always have been prevented relatively easily. Up to date, guidelines summarizing the available evidence into unambiguous recommendations are needed to guide healthcare professionals in the prevention, diagnosis and treatment for infants with hyperbilirubinaemia.
authors.affiliation: Department of Neonatology, Beatrix Children's Hospital, University Medical Center Groningen, Hanzeplein 1, Groningen, the Netherlands. p.h.dijk@umcg.nl
authors.forename: Peter H
authors.initials: PH
authors.lastname: Dijk
authors.forename: Christian V
authors.initials: CV
authors.lastname: Hulzebos
mesh_terms: D006801:Humans; D051556:Hyperbilirubinemia, Neonatal / Q000628:therapy*; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000628:therapy; D007647:Kernicterus / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic